Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Rite Aid files for Chapter 11 amid declining sales and opioid crisis lawsuits

EditorMalvika Gurung
Published 10/15/2023, 11:46 PM
© Reuters.
US90274J5618=UBSS
-

Rite Aid (NYSE:RAD), once the largest pharmacy chain in the US, has filed for Chapter 11 bankruptcy protection to a mounting debt crisis, declining sales, and ongoing lawsuits related to its alleged role in the opioid crisis. The company is grappling with major creditors including McKesson Corporation (NYSE:MCK) and Humana (NYSE:HUM) Health. The Justice Department has accused Rite Aid of filling excessive opioid prescriptions, a claim the company denies.

The pharmacy chain has faced stiff competition from larger rivals such as CVS, Walgreens Boots Alliance (NASDAQ:WBA), and Amazon (NASDAQ:AMZN), which has led to falling sales and less money available for investment and debt repayment. As of June, Rite Aid had $3.3 billion in debt excluding pending opioid litigation. Its share price has plummeted nearly 81% since the beginning of the year, which aligns with the InvestingPro data showing a year-to-date price total return of -80.59%.

Sarah Foss of Debtwire sees Chapter 11 as the only feasible solution for Rite Aid to navigate this perfect storm of issues. The company has been implementing a downsizing strategy that includes closing stores and planning to shut hundreds more, further eroding its competitive position. This aligns with InvestingPro Tips highlighting that Rite Aid has been quickly burning through cash and its revenue has been declining at an accelerating rate.

Rite Aid's pharmacy benefit manager, Elixir, which was acquired in 2015 for $2 billion, struggles to compete with industry giants due to its smaller scale. This puts Elixir at a disadvantage when negotiating larger contracts that could generate more cash flow. A failed merger with Walgreens in 2017 resulted in Rite Aid selling over 2,000 stores and three distribution centers to Walgreens for $5.18 billion. Another attempted merger with grocery chain Albertsons (NYSE:ACI) was called off in 2018 due to lack of shareholder support.

During the pandemic, Rite Aid initially saw a sales boost as customers stocked up on sanitizers and beauty products. However, as customers started consolidating their trips to drugstores, Rite Aid's impulse purchases declined significantly.

Rite Aid was originally established as Thrif D Discount Center in Scranton, Pennsylvania in 1962 before rebranding to Rite Aid in 1968. It underwent rapid expansion across the U.S., becoming the country's largest drugstore chain at one point. In the late 1990s and early 2000s, Rite Aid was embroiled in a securities and accounting fraud case that forced it to restate earnings by $1.6 billion.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.